Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
Yuen Lam Dora Ng(Jiangxi University of Traditional Chinese Medicine), Jan Krönke(Universitätsmedizin Greifswald)
Cited by 67
Related Papers
Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
|Journal of Clinical Oncology|2011|393
Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)
|Leukemia|2019|28
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation
|Annals of the Rheumatic Diseases|2025|15